Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Philip Morris International Inc and Altria establish strategic framework to commercialize reduced-risk products and e-cigarettes


Friday, 20 Dec 2013 08:00am EST 

Philip Morris International Inc (PMI):Establishes a strategic framework with Altria Group, Inc. to commercialize reduced-risk products and e-cigarettes.Says under the terms of a set of agreements, Altria will make available its e-cigarette products exclusively to PMI for commercialization outside the United States (US) and PMI will make available two of its candidate reduced-risk tobacco products exclusively to Altria for commercialization in US.Says in US it is envisaged that PMI’s products would be regulated as Modified Risk Tobacco Products and any commercialization would be subject to U.S. Food and Drug Administration (FDA) authorization.Says the agreements also provide for cooperation on the scientific assessment and regulatory engagement and authorization related to these products with the FDA, among others.